EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Anti-dsDNA Response After Pulse Cyclophosphamide Therapy, with Early Proteinuria Trend as a Secondary Finding

Md. Raisul Islam, Md. Imtiazul Islam, Mehedi Hasan

Annals of International Medical and Dental Research · 2026-08 · 12 (4) · 29-35

DOI: 10.53339/aimdr.2026.12.4.5 ↗
AbstractBibliografische Angaben

Abstract

Background: Lupus nephritis is a major renal manifestation of systemic lupus erythematosus and requires close monitoring of immunological and urinary response after induction therapy. Anti-dsDNA level and proteinuria are commonly used markers of disease activity and treatment response in routine clinical practice. Objective: To assess anti-dsDNA response after pulse cyclophosphamide therapy among patients with lupus nephritis, with early proteinuria trend as a secondary finding. Methods: This retrospective observational study was conducted at Khwaja Yunus Ali Medical College & Hospital from July to December 2025 among 34 patients with lupus nephritis or SLE-related renal syndrome receiving pulse cyclophosphamide therapy. Clinical features, anti-dsDNA levels, and proteinuria grades were analyzed. Data were expressed as frequency, percentage, median, and interquartile range, with paired non-parametric tests used for analysis. A P-value

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →